eISSN: 1689-3530
ISSN: 0867-4361
Alcoholism and Drug Addiction/Alkoholizm i Narkomania
Current issue Archive Articles in press About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
3/2018
vol. 31
 
Share:
Share:
more
 
 
abstract:
Review article

Methadone or buprenorphine? The choice of substitution therapy in pregnant opioid dependent women

Jadwiga Zalewska-Kaszubska

Alcohol Drug Addict 2018; 31 (3): 213-224
Online publish date: 2019/01/16
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Pregnant opioid dependent women have an increased risk of complications both during pregnancy and delivery. Substitution therapy can considerably reduce this risk. Unfortunately, this treatment is not without its side effects, often associated with neonatal abstinence syndrome (NAS), which requires treatment. Methadone and buprenorphine used as substitution therapy, mitigate extreme fluctuations in the concentration of opioids in the blood, which may occur during uncontrolled opioids abuse. The use of buprenorphine is associated with a lower risk of premature delivery, milder withdrawal symptoms and better neonatal health. However, women receiving buprenorphine discontinued therapy more often. Therefore, methadone is preferred in substitution therapy, especially in women who require higher doses of opioids in order to achieve homeostasis.
keywords:

Pregnancy, Buprenorphine, Methadone, Substitution therapy

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe